Johnson & Johnson (JNJ.N)
Sept 18 The following are the top stories on the
business pages of British newspapers. Reuters has not verified
these stories and does not vouch for their accuracy.
* Texas to remain major site for eyecare unit post spin-off
(Adds detail about headquarters in Geneva, comment from CEO)
* J&J to compensate those suffering due to ASR implant in
MUMBAI, Sept 7 Johnson & Johnson (J&J)
said on Friday it would work with the Indian government to
compensate patients who suffered from artificial hip implants
the U.S. healthcare company recalled eight years ago.
CARACAS/VALENCIA, Venezuela, Aug 31 Unilever's
factory in the outskirts of the northern Venezuelan city of
Valencia once bustled with activity as it produced everything
from soap to toothpaste for one of South America's wealthiest
* Stryker's shares down 1 pct
(Adds analysts comments; updates share prices)
Aug 29 The U.S. Food and Drug Administration
(FDA) said on Wednesday a serious genital infection has been
reported in patients taking a certain class of diabetes drugs,
with one death and 11 others hospitalized.
ZURICH, Aug 28 Roche diagnostics head
Roland Diggelmann is resigning as of Sept. 30, ending a 10-year
stint at the Swiss drugmaker and for now leaving the business
with 12.1 billion Swiss francs ($12.15 billion) in sales without
a permanent leader.
FRANKFURT, Aug 27 Bayer and Johnson &
Johnson's campaign to widen the patient group for their
heart drug Xarelto hit a snag when two smaller studies failed to
show a statistically reliant benefit.
LOS ANGELES, Aug 23 A new front in the battle
over the cost of expensive medicines in the United States is
opening up in Oklahoma, the first state where the government's
Medicaid program is negotiating contracts for prescription drugs
based on how well they work.
|General Electric Company (GE.N)||$12.59||-0.12|
|Procter & Gamble Co (PG.N)||$83.80||-0.45|
|Pfizer Inc. (PFE.N)||$43.32||+0.31|
|Novartis AG (NOVN.S)||CHF81.50||-0.34|
|Merck & Co., Inc. (MRK.N)||$70.42||0.00|
|Baxter International Inc (BAX.N)||$77.34||+0.30|
|Stryker Corporation (SYK.N)||$172.01||+2.13|
|Boston Scientific Corporation (BSX.N)||$37.41||+0.14|
|Zimmer Biomet Holdings Inc (ZBH.N)||$130.09||+0.54|